Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.

The Journal of Pediatrics
Cystic Fibrosis FoundationFrank J Accurso

Abstract

Through early detection, newborn screening (NBS)(1) for cystic fibrosis (CF) offers the opportunity for early intervention and improved outcomes. NBS programs screen for hypertrypsinogenemia, and most also identify mutations in the CF transmembrane conductance regulator (CFTR) gene. Individuals identified by NBS are diagnosed with CF if they have an elevated sweat chloride level or if they have inherited 2 disease-causing mutations in the CFTR gene. Mutations in the CFTR gene can cause CF, but not all CFTR mutations are disease-causing. The term CFTR-related metabolic syndrome (CRMS) is proposed to describe infants identified by hypertrypsinogenemia on NBS who have sweat chloride values <60 mmol/L and up to 2 CFTR mutations, at least 1 of which is not clearly categorized as a "CF-causing mutation," thus they do not meet CF Foundation guidelines for the diagnosis of CF. With what is now near-universal CF NBS in the United States, an increasing number of infants with CRMS are being identified. Given our inadequate knowledge of the natural history of CRMS, standards for diagnosis, monitoring, and treatment are absent. This document aims to help guide the monitoring and care of individuals with CRMS while our knowledge base on appr...Continue Reading

References

Jun 1, 1995·The New England Journal of Medicine·M ChillónM Claustres
Jun 22, 1999·JAMA : the Journal of the American Medical Association·V MakK A Jarvi
Jul 10, 1999·Journal of Pediatric Gastroenterology and Nutrition·S Nousia-ArvanitakisM Xefteri
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·P G NooneM R Knowles
May 31, 2001·European Journal of Clinical Investigation·J Walkowiak, K H Herzig
Aug 9, 2001·The European Respiratory Journal·R J MassieC Robertson
Jun 7, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lisa SaimanUNKNOWN Cystic Fibrosis Foundation
Sep 5, 2003·Human Mutation·Delphine FeldmannEmmanuelle Girodon
Oct 6, 2005·The Journal of Pediatrics·Anne Marie ComeauRoger B Eaton
Nov 4, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·D PeckhamK Webb
Jan 24, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·A LordingC J Taylor
Jan 24, 2006·Pediatric Pulmonology·H MussaffiH Blau
Jan 4, 2007·Pediatrics·Erika J SimsUNKNOWN United Kingdom Cystic Fibrosis Database Steering Committee
May 23, 2007·Pediatric Research·Bart E Van EwijkCornelis K Van der Ent
Jul 17, 2007·Journal of Inherited Metabolic Disease·M RousseyC Férec
May 6, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·C CastellaniJ S Elborn
May 30, 2008·Respiratory Research·Isabelle FajacThierry Bienvenu
Jul 22, 2008·The Journal of Pediatrics·Philip M FarrellUNKNOWN Cystic Fibrosis Foundation
Oct 30, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·S J MayellUNKNOWN European Cystic Fibrosis Society Neonatal Screening Working Group
Feb 6, 2010·The Journal of Pediatrics·UNKNOWN Cystic Fibrosis FoundationFrank J Accurso

❮ Previous
Next ❯

Citations

Jun 4, 2010·Journal of Inherited Metabolic Disease·Jaime E HaleAnne Marie Comeau
Jun 29, 2011·Epidemiologic Reviews·Wylie BurkeJames P Evans
May 8, 2010·American Journal of Respiratory and Critical Care Medicine·Jerry A NickMarci K Sontag
Oct 17, 2012·American Journal of Respiratory and Critical Care Medicine·Theresa A Laguna
May 3, 2014·Pediatrics in Review·Shruti M Paranjape, Peter J Mogayzel
May 28, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Michael J RockJens Eickhoff
May 9, 2012·Annual Review of Genomics and Human Genetics·Beth A Tarini, Aaron J Goldenberg
Jul 20, 2014·Advances in Pediatrics·Stacey L MartinianoEdith T Zemanick
Feb 10, 2016·Clinics in Chest Medicine·Kimberly A Spoonhower, Pamela B Davis
Feb 10, 2016·Clinics in Chest Medicine·John Brewington, J P Clancy
Jun 23, 2015·Pediatric Pulmonology·Denise M KayUNKNOWN New York State Cystic Fibrosis Newborn Screening Consortium
Apr 1, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Danieli Barino SalinasMartin Kharrazi
Jan 30, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·A MunckUNKNOWN ECFS Neonatal Screening Working Group
Oct 18, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Susanna A McColley
Jun 26, 2013·Current Problems in Pediatric and Adolescent Health Care·Gary A MuellerCharlotte Lemming
Mar 8, 2013·Paediatric Respiratory Reviews·Carlo Castellani, UNKNOWN CFTR2 team
Mar 20, 2014·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Audrey Tluczek, Jane M De Luca
Dec 6, 2011·Molecular Genetics and Metabolism·S K CordovadoP W Mueller
Nov 26, 2009·Pediatric Clinics of North America·Suzanne H MichelMaria Mascarenhas
Dec 18, 2010·Pediatric Annals·Michael J Rock, Jack K Sharp
Nov 27, 2014·Annals of Neurology·Michele A ScullyJennifer M Kwon
Apr 8, 2016·The Lancet. Respiratory Medicine·Carlo CastellaniKevin W Southern
Jun 14, 2015·The Lancet. Respiratory Medicine·Richard B MossUNKNOWN VX11-770-110 (KONDUCT) Study Group
Jun 19, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Carlo CastellaniUNKNOWN Veneto CF Lab Network
Mar 31, 2015·The Journal of Pediatrics·Tyler GrovesDominic A Fitzgerald
May 27, 2015·The Journal of Pediatrics·Hara Levy, Philip M Farrell
Jan 1, 2015·Nature Reviews. Disease Primers·Felix RatjenAndrew Bush
Apr 7, 2015·Mayo Clinic Proceedings·Benjamin R GriffinMark E Wylam
Jul 3, 2013·The Journal of Molecular Diagnostics : JMD·Lisa PrachUNKNOWN California Cystic Fibrosis Newborn Screening Consortium
Aug 13, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Drucy BorowitzUNKNOWN Liprotamase 726 Study Group
Aug 23, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Megan R NelsonAudrey Tluczek
Jan 3, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Steven KeilesUNKNOWN California Cystic Fibrosis Newborn Screening Consortium
Feb 13, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Mei W BakerPhilip M Farrell
Jun 4, 2016·The Journal of Pediatrics·Martin Kharrazi
Jul 23, 2016·Genetic Testing and Molecular Biomarkers·Danieli Barino SalinasRichard B Parad
Jul 30, 2016·Pediatric Clinics of North America·Margaret RosenfeldClement L Ren
Jul 30, 2016·Pediatric Clinics of North America·Don B Sanders, Aliza K Fink
Jul 30, 2016·Pediatric Clinics of North America·Patrick R SosnayRonald L Gibson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Sarah J MayellEuropean Cystic Fibrosis Society Neonatal Screening Working Group
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Isabelle Sermet-GaudelusEuropean Cystic Finrosis Society (ECFS), Neonatal Screening Working Group
© 2022 Meta ULC. All rights reserved